ArticlePDF Available

Transpyloric feeding in gastroesophageal-reflux-associated apnea in premature infants

Authors:
  • Summerville Medical Center

Abstract and Figures

The aetiological role of gastroesophageal reflux in apnea of prematurity is controversial. We hypothesized that transpyloric feeds, which decreases reflux and aspiration, will not be associated with decrease in reflux-related apnea. The shows retrospective chart review of 41 premature babies on transpyloric feeds. Fifteen infants meeting the inclusion criteria of apnea of prematurity and clinical evidence of gastroesophageal reflux were included. Primary data points were number of apneas before and after transpyloric feeds. t-statistics was used for analysis. Twelve of the 15 babies showed significant improvement on transpyloric feeds (p <. 005). The nonresponders were identified within 48 h. After discontinuation of transpyloric feeds, 2 responders underwent antireflux surgery and 9 were discharged without further intervention. No transpyloric-tube-related complication was documented. Transpyloric feeds may be useful for diagnosis and management of suspected gastroesophageal-reflux-associated apnea in a selected group of infants.
Content may be subject to copyright.
Acta Pædiatrica ISSN 0803–5253
REGULAR ARTICLE
Transpyloric feeding in gastroesophageal-reflux–associated apnea
in premature infants
Sudipta Misra (smisra@pol.net)1, Kamlesh Macwan2, Viola Albert2
1.Divisions of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of Illinois College of Medicine at Peoria and Children’s Hospital
of Illinois at OSF St. Francis Hospital, Peoria, Illinois, USA
2.Division of Neonatology, Department of Pediatrics, University of Illinois College of Medicine at Peoria and Children’s Hospital of Illinois at OSF St. Francis Hospital, Peoria,
Illinois, USA
Keywords
Apnea of prematurity, Gastroesophageal reflux,
Transpyloric feeding, Tube feeding
Correspondence
Sudipta Misra, Children’s Medical Center, MCG,
1446 Harper Street, Augusta, GA 30913, USA.
Tel.: (706) 721 4724 |Fa x: (706) 721 3791 |
Email: smisra@pol.net
Received
14 February 2007; revised 30 April 2007; accepted
27 June 2007.
DOI:10.1111/j.1651-2227.2007.00442.x
Abstract
Objective: The aetiological role of gastroesophageal reflux in apnea of prematurity is controversial. We
hypothesized that transpyloric feeds, which decreases reflux and aspiration, will not be associated
with decrease in reflux-related apnea.
Study design: The shows retrospective chart review of 41 premature babies on transpyloric feeds.
Fifteen infants meeting the inclusion criteria of apnea of prematurity and clinical evidence of
gastroesophageal reflux were included. Primary data points were number of apneas before and after
transpyloric feeds. t-statistics was used for analysis.
Results: Twelve of the 15 babies showed significant improvement on transpyloric feeds (p <. 005).
The nonresponders were identified within 48 h. After discontinuation of transpyloric feeds, 2
responders underwent antireflux surgery and 9 were discharged without further intervention. No
transpyloric-tube–related complication was documented.
Conclusion: Transpyloric feeds may be useful for diagnosis and management of suspected
gastroesophageal-reflux–associated apnea in a selected group of infants.
INTRODUCTION
Apnea is a common problem in premature newborns (1).
Gastroesophageal reflux is often implicated as one of the
aetiological factors. Empirical antireflux therapy is com-
mon in many neonatal intensive care units. Invasive diag-
nostic tests, such as long-term pH probe studies, are often
ordered to diagnose reflux. However, both apnea and re-
flux are common in premature newborns. A definite cause
and effect relationship between apnea and reflux has not
been established. Initial studies suggested gastroesophageal
reflux as an aetiological factor (2–4). However, that claim
has been disputed (5,6). Limitations of diagnostic tests for
reflux as well as its sporadic nature further complicate the
issue.
Small-bowel feeding has been shown to cause less gastroe-
sophageal reflux by radiolabel formula infusion study (7). We
hypothesized that if apnea is caused by gastroesophageal re-
flux then transpyloric feeds will not be associated with a
significant reduction of number of apneas.
METHODS
In this retrospective observational study, we reviewed the
records of premature newborns on transpyloric feeds be-
tween July 2000 and June 2004 at the neonatal intensive
care unit of the Children’s Hospital of Illinois at OSF St
Francis Hospital at Peoria, Illinois. In our newborn unit,
transpyloric feed is commonly used in suspected reflux-
associated apnea per protocol (see Fig. S1). Inclusion cri-
teria for this study were: (i) Newborns meeting the criteria
of apnea of prematurity as documented in the ‘apnea sheet.’
Apnea of prematurity was defined as sudden cessation of
breathing that lasted for at least 20 sec or was accompanied
by bradycardia or oxygen desaturation (cyanosis) in an in-
fant younger than 37 weeks gestational age (8). (ii) Common
causes of apnea, such as infection, metabolic abnormalities,
hypo or hyperthermia, hypoxia, anaemia, arrhythmias, and
medications, such as prostaglandin, upper airway malfor-
mations, sepsis, intracranial bleed, necrotizing enterocolitis,
etc, were excluded as aetiology. (iii) Clinical evidence of gas-
troesophageal reflux, such as significant vomiting, regurgita-
tion, and/or esophageal symptoms, such as arching back,
feeding difficulty, irritability, etc. (iv) Ineffective therapeutic
trials with caffeine.
Eight Fr Kendall Argyle IndwellTM (Tyco Healthcare
Group LP, Mansfield, MA) polyurethane nonweighed feed-
ing tubes were used. These were placed like nasogastric tubes
with 8–10 cm of excess length. The infant was placed in a
45angle on the right side to facilitate passage of the tube in
the duodenum. Transpyloric position of the tip of the tube
was confirmed by abdominal X-ray before starting continu-
ous feed with a pump. Numbers of apneas in 48 h before and
after transpyloric feeds were recorded. Thus the mean num-
ber of apneas/day was calculated in each infant. Readiness
for oral feeding was assessed in each infant per protocol.
However, the decision to discontinue transpyloric feedings
was made by the attending neonatologists according to clin-
ical condition and readiness of the baby to feed. Descriptive
and t-statistics were used for analysis. A p-value of less than
0.05 was taken to be statistically significant. The Institutional
1426 C
2007 The Author(s)/Journal Compilation C
2007 Foundation Acta Pædiatrica/Acta Pædiatrica 2007 96, pp. 1426–1429
Misra et al. Gastroesophageal reflux and apnea in premature infants
Table 1 Reason for transpyloric feed in newborns (n =41)
Apnea 21
Desaturation only 18
Vomiting/aspiration 1
Unknown 1
Review Board of the UIC College of Medicine at Peoria ap-
proved this study.
RESULTS
Forty-one newborns were put on transpyloric feeding be-
tween December 2001 and June 2004. Though 21 infants
were started on transpyloric feeds for apnea (Table 1), on
review of the ‘apnea sheet’ only 15 met the criteria for apnea
of prematurity (8).
The mean gestational age and birth weight of these 15
infants were 27.6 ±2.9 weeks (range 24–36.3 weeks) and
1083.1 ±371.2 g (range 680–2190 g), respectively. Eleven
of these infants were below 28 weeks of gestation at birth.
Comorbid conditions included sepsis, chronic lung disease,
intraventricular haemorrhage, etc (Table 2). These comor-
bid conditions were passive or stable at the time of start-
ing transpyloric feeds and could not account for the apnea.
Before initiation of transpyloric feeds, 9 infants were on
combinations of ranitidine and metoclopramide; one each
received only ranitidine and metoclopramide. Two infants
received additional oral omeprazole. On transpyloric feeds,
there was no significant difference in the number of apneas
among 6 infants who were on antacids and/or prokinetics
and 7 who were not. Transpyloric feeding was initiated at
a mean chronological age of 32.25 ±9.34 days (range 20–
51 days) and continued for an average of 16.9 ±14.5 days
(range 2–48 days, median 10 days).
0
1
2
3
4
5
6
7
8
9
1 2
Bef or e and af t e r ND f ee ds
Responders = Continuous Lines
Non-Responders = Broken Lines
Figure 1 Mean number of apneas before and after transpyloric feeds (apnea/24 h, n =15). Responders =continuous lines; nonresponders =broken lines.
Table 2 Co-morbid conditions in newborns with apnea (n =15)
Extreme prematurity 11
Sepsis 7
Chronic lung disease 8
Intraventricular haemorrhage 2
Necrotizing enterocolitis 2
Others 12
Includes multiple diagnoses in individual subjects.
On transpyloric feeds, 12 infants had documented reduc-
tion of apneas. The mean number of apneas in the whole
group decreased from 2.43/days (range 1–8, median 2) to
1.06/days (range 0–3, median 1; p <0.05 by paired t-test).
Three infants did not respond to transpyloric feeds, 2 had
no change in numbers of apneas whereas 1 had more ap-
neic spells (Fig. 1). Four infants had less than two doc-
umented apneic episodes per day for 3 consecutive days
before transpyloric feeds were initiated. Apneic episodes
improved in two (50%) of them on transpyloric feeds. Vom-
iting and/or regurgitation resolved in all babies on transpy-
loric feeding. Review of medical records of all 41 infants did
not reveal complications, such as intestinal perforation, peri-
tonitis, gastrointestinal haemorrhage, migration of the tube
to the abdominal or thoracic cavity, etc, that could be related
to transpyloric tube feeding.
Among the 12 newborns that responded to transpyloric
feeding, 2 underwent antireflux surgery, one due to recur-
rence of symptoms after discontinuation of transpyloric feed
and the other along with a gastrostomy tube placement for
poor feeding. One baby was transferred to another facil-
ity while on transpyloric feeds and was lost to follow-up.
The remaining newborns were discharged home on oral
feeds.
C
2007 The Author(s)/Journal Compilation C
2007 Foundation Acta Pædiatrica/Acta Pædiatrica 2007 96, pp. 1426–1429 1427
Gastroesophageal reflux and apnea in premature infants Misra et al.
DISCUSSION
The role of gastroesophageal reflux in apnea of prematurity
is controversial. Co-existence and possible aetiological re-
lationship between gastroesophageal reflux and apnea have
been widely reported(2–4). Recent studies in a small number
of infants using sophisticated techniques have failed to con-
firm an aetiological role of gastroesophageal reflux in apnea
of prematurity (5,6). However, such studies are complicated
by unreliable diagnostic techniques, day-to-day variability of
reflux and lack of studies with appropriate sample size and
power (9,10). Upper gastrointestinal barium X-ray is not rec-
ommended as a diagnostic test for gastroesophageal reflux
(11), and pH probe studies are limited by acid-neutralizing
capability of most formulas and inability to detect non-acid
refluxes that can cause aspiration (9). In fact, clinical indi-
cators, such as vomiting, arching back, coughing, etc, may
be more useful for a presumptive diagnosis of reflux in pre-
mature infants than invasive tests.
In this case series, we have explored a simple logical ther-
apeutic approach to evaluate the causal effect of gastroe-
sophageal reflux on apnea. In our institution transpyloric
feed is being used as an empirical therapy for apnea and
desaturation suspected to be due to gastroesophageal re-
flux (see Fig. S1). We have discontinued using invasive tests
to document gastroesophageal reflux as these are of doubt-
ful value and mere co-existence of two conditions does not
prove their aetiological role. For the purpose of this study,
we included only those with clearly documented apnea in
the neonatal records. Usual causes of apnea were excluded
in these infants. They did not respond to usual therapeutic
measures to control apnea. These babies had clinical indica-
tors of reflux and most of these babies had failed ‘standard’
pharmacotherapy to control gastroesophageal reflux.
Four babies had less than two apneic episodes/day for
3 consecutive days. Use of strict inclusion criteria for ap-
nea might have excluded episodes that were of clinical con-
cern in these babies but did not meet the criteria. Though
the possibility that these apneic episodes were due to day-
to-day variation of respiratory pattern cannot be ruled out,
they were persistent, recurring and were nonresponsive to
usual therapy. Half of these babies responded to transpy-
loric feeding. Transpyloric feeding has been extensively used
in newborns for enteral feeding (12). It is less likely to cause
gastroesophageal reflux (7). Transpyloric feeding has been
shown to significantly decrease the incidence of aspiration
when compared to intragastric feeds (13). So, if the apnea
was related to gastroesophageal reflux, transpyloric feed-
ing should result in significant improvement. Those without
reflux-related apnea would not benefit from this interven-
tion. In our study, responders were distinguished from non-
responders within 48 h of starting transpyloric feeds (Fig. 1).
The decrease in the number of apneas after starting transpy-
loric feeds was statistically significant. Nine of the 12 babies
did not have recurrence of apnea after discontinuation of
transpyloric feeds. Age-related maturity of gastrointestinal
function and improved nutrition may account for nonrecur-
rence of apnea after discontinuation of transpyloric feeds
(1,14).
Concerns have been expressed about transpyloric-tube–
related complications in newborns (12). However, no per-
foration with or without complication was reported in this
meta-analysis. Authors acknowledged that the increased in-
cidence of ‘gastrointestinal symptoms’ and mortality might
have been caused by one large study with possible assign-
ment bias. We routinely use small-calibre soft polyurethane
nonweighed feeding tubes. No such complications were en-
countered in our entire patient population (n =41) as well in
other areas of Children’s Hospital where this form of feeding
is used frequently.
This is an uncontrolled empirical study in a small number
of subjects selected after multiple layers of clinical screening.
It explores a novel, common sense; inexpensive approach to
managing infants suspected of having apnea due to reflux
and avoids expensive invasive tests of doubtful value.
We conclude that continuous transpyloric feeding is a
safe and useful diagnostic and therapeutic option in a select
group of newborns with apnea of prematurity, suspected to
be due to gastroesophageal reflux. A prospective multicen-
tre study with appropriate power is warranted to explore this
simple inexpensive approach.
References
1. Alexander DC, Robin B. Neonatology. In: Sieberry GK,
Iannone R, editors. The Harriet Lane handbook. 15th ed. St.
Louis, MO: Mosby, Inc., 2003: 417–38.
2. Menon AP, Scheff GL, Thach BT. Apnea associated with
regurgitation in infants. J Pediatr 1985; 106: 625–9.
3. Spitzer AR, Boyle JT, Tuchman DN, Fox WW. Awake apnea
associated with gastroesophageal reflux: a specific clinical
syndrome. J Pediatr 1984; 104: 200–5.
4. Ornstein SR. Infantile reflux: different from adult reflux. Am J
Med 1997; 103: 114s–9.
5. Wenzl TG, Schenke S, Peschgens T, Silny J, Heimann G,
Skopnik H. Association of apnea and nonacid
gastroesophageal reflux in infants: investigations with
intraluminal impedance technique. Pediatr Pulmonol 2001;
31: 144–9.
6. Mousa H, Woodley FW, Metheney M, Hayes J. Testing the
association between gastroesophageal reflux and apnea in
infants. J Pediatr Gastroenterol Nutr 2005; 41: 169–77.
7. McClave AS, DeMeo MT, DeLegge MH, DiSario MD,
Heyland DK, Maloney JP, et al. North American summit on
aspiration in the critically ill patient: consensus statement. J
Parenteral Enteral Nutr 2002; 26: S80–5.
8. Committee on Fetus and Newborn. American Academy of
Pediatrics. Apnea, sudden infant death syndrome, and home
monitoring. Pediatrics 2003; 111: 914–7.
9. Mitchell DJ, McClure BG, Tubman TR. Simultaneous
monitoring of gastric and esophageal pH reveals limitations of
conventional esophageal pH monitoring in milk fed infants.
Arch Dis Child 2001; 84: 273–6.
10. Ornstein SR. Tests to assess symptoms of gastroesophageal
reflux in infants and children. J Pediatr Gastroneterol Nutr
2003; 37: S29–32.
11. Rudolph CD. Guidelines for evaluation and treatment of
gastroesophageal reflux in infants and children:
recommendations of the North American Society for Pediatric
Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr
2001; 32: S1–3.
1428 C
2007 The Author(s)/Journal Compilation C
2007 Foundation Acta Pædiatrica/Acta Pædiatrica 2007 96, pp. 1426–1429
Misra et al. Gastroesophageal reflux and apnea in premature infants
12. McGuire W, McEwan P. Systemic review of transpyloric
versus gastric tube feeds for preterm infants. Arch Dis Child
Fetal Neonatal Ed 2004; 89: F245–48.
13. Methany NA, Clouse RE, Chang YH, Steward BJ, Oliver DA,
Kollef MH. Tracheobronchial aspiration of gastric content in
critically ill tube-fed patients: frequency, outcome and risk
factors. Crit Care Med 2006; 34: 1007–15.
14. Nelson SP, Chen EH, Syniar GM, Christoffel KK. Prevalence
of symptoms of gastroesophageal reflux: a pediatric practice
based study. Pediatric Research Group. Arch Pediatr Adolesc
Med 151: 569–72; 1997.
Supplementary material
The following supplementary material is available for this
article:
Figure S1 Modified from Berman S. Neonatal apnea in pe-
diatric decision making. Berman S., editor, 1st ed. Philadel-
phia, PA: B. C. Decker, Inc., 1984: 52–3.
This material is available as part of the online article from:
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1651-
2227.2007.00442.x
(This link will take you to the article abstract).
Please note: Blackwell Publishing is not responsible for the
content or functionality of any supplementary materials sup-
plied by the authors. Any queries (other than missing mate-
rial) should be directed to the corresponding author for the
article.
C
2007 The Author(s)/Journal Compilation C
2007 Foundation Acta Pædiatrica/Acta Pædiatrica 2007 96, pp. 1426–1429 1429
... Two retrospective studies have reported transpyloric feeds, which reduce reflux, to be effective in reducing apnea in premature babies. 12,13 We designed this prospective study to test the hypothesis that transpyloric feeds may help reduce apnea in selected premature newborns. Inclusion criteria included preterm (gestational age less than 37 weeks) neonates born at the institution and admitted to the neonatal intensive care unit (NICU) were included in the study if, 1) They were on enteral feeds of more than 20 ml/kg/day. ...
... Transpyloric placement of the non-weighed polyurethane feeding tube was done at the bedside by the previously described technique. 12 Appropriate placement of the tube was confirmed with an abdominal X-ray. The neonates had continuous transpyloric feeding of human milk with a pump for 72 hours. ...
... In a retrospective study, Misra et al observed a reduction in apnea in 12 out of 15 premature neonates treated with transpyloric feeding due to clinically suspected GER. 12 These authors also reported a significant decrease in the mean number of apneic episodes. Similarly, Malcolm et al showed a reduction in the combined number of apnea episodes from 4 to 2.5 in 72 hours pre-and post-transpyloric feeding, respectively, in a retrospective report on 72 very low birth weight neonates. ...
Article
Full-text available
Background: The etiological correlation between gastroesophageal reflux (GER) and apnea is controversial. We conducted a prospective interventional study designed to address the controversy. Methods: Preterm neonates with apnea at a tertiary care center, who had clinical features of GER without any other comorbidities likely to cause apnea, were included in the study. The enrolled neonates underwent continuous transpyloric tube feeding for 72 hours. The primary outcome measure was the difference in the number of apneic episodes pre- and post-initiation of nasoduodenal (ND) feeding. Secondary outcome measures included the incidence of necrotizing enterocolitis, other gastrointestinal disturbances, and mortality. Results: Sixteen preterm neonates were included in the study. A substantial proportion (n =11, 68.8%) of the included neonates had a reduction in the number of apneic episodes. There was a significant decrease in the mean number of apneic episodes from 1.75 (±0.837) to 0.969 (±0.957) (P=.007). The median number of apneas was 1.5 (IQR 0.875) before and 0.5 (IQR 0.875) after ND feeds. There were no serious adverse events observed that were attributable to transpyloric feeding. Conclusion: This prospective study suggests that in a selected group of preterm neonates with reflux- associated apnea, transpyloric feeding can be an effective therapeutic modality.
... The role of transpyloric feeding in patients with GERD and extra-esophageal involvement is better documented in the literature, particularly in neonates and in children with neurological impairment [23][24][25][26]. Studies investigating the role of transpyloric feeds in managing neonates with suspected GERD and extra-esophageal manifestations found that transpyloric feeds may be associated with a reduction in episodes of apnea and bradycardia [23,24]. ...
... The role of transpyloric feeding in patients with GERD and extra-esophageal involvement is better documented in the literature, particularly in neonates and in children with neurological impairment [23][24][25][26]. Studies investigating the role of transpyloric feeds in managing neonates with suspected GERD and extra-esophageal manifestations found that transpyloric feeds may be associated with a reduction in episodes of apnea and bradycardia [23,24]. On the other hand, in a study comparing transpyloric feeding to Nissen fundoplication in neurologically impaired children, Srivastava et al. found that those receiving transpyloric feeding did not differ in the number of hospitalizations for aspiration pneumonia nor overall survival [25]. ...
Article
Full-text available
Purpose of Review Gastroesophageal reflux disease (GERD) is a common pediatric condition that can present with a wide array of esophageal and extra-esophageal manifestations. In addition to examining the association between GERD and extra-esophageal manifestations, this review will explore the various diagnostic and treatment strategies for patients with the disorder. Recent Findings Combined pH and multichannel intraluminal impedance (pH-MII), in contrast to isolated pH probe monitoring, can detect both full-column reflux events and non-acid reflux events, allowing greater insight into the potential pathophysiology of extra-esophageal manifestations. Studies have thus far failed to show a significant benefit from treating presumed extra-esophageal manifestations with either proton-pump inhibitors (PPI) or H2-receptor antagonists (H2-RA); similarly, researchers have yet to consistently prove any benefit from anti-reflux surgery on extra-esophageal manifestations. Summary The association between GERD and extra-esophageal manifestations remains poorly defined, due in part to a paucity in mechanistic studies investigating a causal link between them. From a diagnostic standpoint, while combined pH-MII has enabled greater insight into the pathophysiology of extra-esophageal manifestations, studies investigating the utility of less-invasive diagnostic modalities for extra-esophageal manifestations, such as measurement of salivary pepsin, remain inconclusive. On the other hand, despite the existence of several pharmacologic, non-pharmacologic, and surgical options, there remains a pressing need for large-scale trials investigating their efficacy in patients with extra-esophageal manifestations.
... However, in terms of mortality and infection, the use of these medications makes no difference in clinical outcomes in critically ill ICU patients [111]. Nevertheless, the use of these medications doesn't affect mortality or infection rates in critically ill ICU patients [112]. In such cases, switching to post-pyloric feeds may be more effective. ...
Article
Full-text available
Purpose of Review Enteral nutrition (EN) therapy can provide vital nutrition support for patients with various medical conditions as long as it is indicated and supported by ethical reasoning. This review seeks to offer a detailed account of the history of EN development, highlighting key milestones and recent advances in the field. Additionally, it covers common complications associated with EN and their management. Recent Findings After years of research and development, we have reached newer generations of enteral feeding formulations, more options for enteral tubes and connectors, and a better understanding of EN therapy challenges. Given the availability of many different formulas, selecting a feeding formula with the best evidence for specific indications for enteral feeding is recommended. Initiation of enteral feeding with standard polymeric formula remains the standard of care. Transition to small-bore connectors remains suboptimal. Summary Evidence-based practices should be followed to recognize and reduce possible enteral feeding complications early.
... Studies have hypothesized that preterm infants suffer from aspiration to a greater or lesser degree depending on gastroesophageal reflux, which is also related to the onset and progression of BPD. 33 As transpyloric tube feeding is effective in reducing the symptoms of gastroesophageal reflux, 34,35 it may also be effective in preventing BPD caused by microaspiration. However, its effectiveness and safety in preterm infants remain unclear. ...
Article
Full-text available
Background: Nowadays, more infants weighing ≤ 300 g are born, and they survive because of the improvements in neonatal care and treatment. However, their detailed clinical course and neonatal intensive care unit management remain unknown due to their low survival rate and dearth of reports. Case Presentation: A male infant was born at 24 weeks and 5 days of gestation and weighed 258 g. The infant received 72 days of invasive and 92 days of noninvasive respiratory support, including high-frequency oscillatory ventilation with volume guarantee and noninvasive neurally adjusted ventilatory assist. Meconium-related ileus was safely treated using diatrizoate. Although he was diagnosed with severe bronchopulmonary dysplasia and retinopathy of prematurity requiring laser photocoagulation, he had no other severe complications. He was discharged 201 days post-delivery (3 months of corrected age) with a weight of 3396 g. Conclusions: Although managing infants weighing ≤ 300 g is difficult, our experience shows that it is possible by combining traditional and modern management methods. The management of such infants requires an understanding of the expected difficulties and adaptation of existing methods to their management. The management techniques described here should help improve their survival and long-term prognosis.
... La cascada de fenómenos relacionados con el RGE que resultan en laringoespasmo y episodios de apneas, es actualmente bien conocido, entre los signos y síntomas respiratorios y otorrinolaringológicos, cuya presencia cataloga a la ERGE como de presentación atípica no usual, se encuentran la apnea (7,8). Estos mecanismos han sido propuestos como causa de lo que en la literatura anglosajona se conoce con la siglas ALTE (Apparent Life Threatening Event) y en la española como EAL (Episodio Aparentemente Letal del lactante) y en algunos casos de muerte súbita (9). ...
Article
Full-text available
RESUMEN La enfermedad por reflujo gastroesofágico (RGE), es la devolución del contenido gástrico dentro del esófago, con elevada morbilidad y mortalidad en los neonatos y lactantes. Se evaluaron los resultados del abordaje por mínima invasión en el tratamiento del reflujo gastroesofágico por bridas duodenales, en neonatos y lactantes menores, atendidos en el Centro Médico Docente la Trinidad y Hospital de Clínicas Caracas entre enero de 2012 y enero de 2020. Se realizó un estudio observacional, retrospectivo. Los resultados muestran un total de 31 pacientes, 60 % sexo masculino, la edad promedio fue de 3 meses. La técnica fue laparoscópica, utilizando 4 puertos 1 de 5 mm y 3 de 3 mm con liberación de bridas duodeno-hepáticas. No hubo conversiones ni complicaciones intra ni posoperatorias. El inicio de la vía oral fue de 24 horas, y el tiempo de hospitalización se presentó en rango de 2 a 10 días. Se concluye que la liberación de bridas duodenales a través de la cirugía mínima invasiva en recién nacidos y lactantes, como tratamiento para el RGE, representa un procedimiento seguro y eficaz, sin necesidad de realizar otras técnicas antirreflejo con Fundoplicatura de Nissen, por lo que el tiempo quirúrgico es menor, menos posibilidades de complicaciones o reintervenciones, por menor manipulación de tejidos, favoreciendo al paciente pediátrico a una rápida recuperación y por ende, menor tiempo de estancia hospitalaria. Palabras clave: Reflujo gastroesofágico, bridas duodenales, cirugía mínima invasiva, laparoscopia.
Article
Background: Nutritional complications have an impact in both short- and long-term morbidity of patients with congenital diaphragmatic hernia (CDH). We aimed to compare time to full enteral tube feeding depending on route -gastric (GT) or transpyloric (TPT)- in newborns with left CDH (L-CDH). Methods: Retrospective cohort study of L-CDH patients admitted to a referral tertiary care NICU between January 2007 and December 2014. Lethal chromosomal abnormalities and death before initiation of enteral nutrition were exclusion criteria. Results: 37 patients were fed through GT, 46 by TPT. TPT children took 11.0 (6.8) days to reach full enteral tube feeding and spent 16.6 (8.1) days on parenteral nutrition vs 16.8 (14.7) days (p = 0.041) and 22.7 (13.5) days (p = 0.020) of GT patients. TPT children had 3.9 (2.4) days of fasting due to GI issues and 20% had episodes of decreased rates of enteral nutrition for extra-GI complications vs 11.4 (11.1) days (p = 0.028) and 49% (p = 0.006). According to the best fitting model (R2 0.383, p < 0.001), the TPT-group achieved full enteral feeding 8.4 days earlier than the GT-group (95% CI -14.76 to - 2.02 days), after adjustment by severity of illness during the first days, o/e LHR_liver and class of diaphragmatic defect. There were no differences in growth outcomes and length of stay between survivors of GT and TPT groups. Conclusion: TPT shortens time to full enteral nutrition, especially in the most severe L-CDH patients. We propose that placement of a TPT at the end of the surgical repair procedure should be considered, especially in higher-risk patients. Level of evidence: Treatment study, Level III. Retrospective comparative, case-control study.
Article
Full-text available
Gastroesophageal reflux (GER) in children is very common and refers to the involuntary passage of gastric contents into the esophagus. This is often physiological and managed conservatively. In contrast, GER disease (GERD) is a less common pathologic process causing troublesome symptoms, which may need medical management. Apart from abnormal transient relaxations of the lower esophageal sphincter, other factors that play a role in the pathogenesis of GERD include defects in esophageal mucosal defense, impaired esophageal and gastric motility and clearance, as well as anatomical defects of the lower esophageal reflux barrier such as hiatal hernia. The clinical manifestations of GERD in young children are varied and nonspecific prompting the necessity for careful diagnostic evaluation. Management should be targeted to the underlying aetiopathogenesis and to limit complications of GERD. The following review focuses on up-to-date information regarding of the pathogenesis, diagnostic evaluation and management of GERD in children.
Article
Unlabelled: Aspiration is common in mechanically ventilated patients and may predispose patients to aspiration pneumonia, chemical pneumonitis, and chronic lung damage. Pepsin A is a specific marker of gastric fluid aspiration and is often detected in ventilated pediatric patients. We investigated the effect of oral care and throat suctioning in the detection of pepsin A in tracheal aspirates (TAs) up to 4 hours after these procedures. Methods: Twelve pediatric patients between age 2 weeks to 14 years who underwent intubation for cardiac surgery were enrolled in this study. Six of the 12 patients were consented before their surgery with initial specimen collected at the time of intubation and last one shortly before extubation (intubation duration < 24 hours). The remaining 6 patients were consented after cardiac surgery. All specimens were collected per routine care per respiratory therapy protocol and shortly before extubation (intubation duration > 24 hours). Tracheal fluid aspirates were collected every 4 to 12 hours in the ventilated patients. Enzymatic assay for gastric pepsin A and protein determination were performed. The time of oral care and throat suctioning within 4 hours prior was recorded prospectively. Results: A total of 342 TA specimens were obtained from the 12 intubated pediatric patients during their course of hospitalization; 287 (83.9%) showed detectable total pepsin (pepsin A and C) enzyme activity (> 6 ng/mL) and 176 (51.5%) samples had detectable pepsin A enzyme levels (>6 ng/mL of pepsin A). Only 29 samples of 76 samples (38.2%) had evidence of microaspiration after receiving oral care, while 147 of 266 (55.3%) samples were pepsin A positive when no oral care was provided. Odds ratio is 0.50 (Cl 0.30-0.84), and the number needed to treat is 5.8 (Confidence interval 3.4-22.3). Testing air filters for pepsin was not beneficial. Conclusion: Oral care is a highly effective measure to prevent microaspiration of gastric fluid in ventilated pediatric patients. The number needed to treat (5.8) suggests this is a very effective prevention strategy. Our study suggests that pepsin A is a useful and sensitive biomarker that allows identification of gastric aspiration.
Article
OBJECTIVE To study the impact of transpyloric feed initiation on short-term oxygenation and manual oxygen blender titration among extremely low birth weight (ELBW) infants. Study design This retrospective study evaluated several measures of oxygenation among ELBW infants receiving positive pressure respiratory support for 96 hours before and after TP tube placement in a single NICU during the years 2017- 2020. The measures included the achieved oxygen saturation (SpO2), the baseline fraction of inspired oxygen (FiO2), the SpO2/ FiO2 ratio, the number and severity of hypoxemic episodes and the frequency of manual oxygen titrations (Titration Index) and were analyzed using an interrupted time series regression approach. RESULTS A total of 56 infants were evaluated. No significant differences were observed in any oxygenation measures during transpyloric vs. gastric feeding among 14 intubated infants. However, among 42 non-intubated patients, significant improvements were observed in the median SpO2/ FiO2 ratios (p= 0.001), median Titration Index (p= 0.05), median number of hypoxemic episodes (p=0.02) and median severity of hypoxemic episodes (p= 0.008) after transpyloric tube placement. CONCLUSIONS The transition from gastric to transpyloric tube feeding was temporally associated with acute improvement in oxygenation for non-intubated infants, but not for intubated infants.
Chapter
The relation between gastroesophageal reflux (GER) and apnoea is still debated both in infants and children. From a mechanistic point of view, acid and non-acid GER may cause apnoea through aspiration of gastric content and vagal reflex that may be also triggered by esophageal distention and inflammation. Nonetheless, glottal closure, a brief apnoea, and cough are physiological protective mechanisms to prevent the entrance of refluxate in the respiratory tract. Moreover, respiratory abnormalities may induce GER by creating negative thoracic pressure or positive abdominal pressure. In the first weeks of life and particularly in premature neonates, cardiorespiratory events, including desaturation, apnoea, and bradycardia may often occur but temporal and causal relationship with regurgitation and reflux are rarely proven. Similarly, children with obstructive sleep apnoea (OSA) are not routinely investigated for GER making the association difficult to establish. Esophageal pH-impedance with simultaneous polysomnography is considered the most useful diagnostic technique to detect GER and its temporal association with respiratory events. Nevertheless, data on infants and children with apnoea are scarce because of technical difficulties, high cost, need for expertise, and limited reference values making the relation between GER or GER-disease and respiratory manifestations difficult to clarify. Acid suppressive agents are often started in patients with recurrent respiratory events without a proven diagnosis of GER-disease. However, pharmacological empirical treatment is not recommended due to lack of evidence of efficacy and possible adverse events.KeywordsRefluxGERRegurgitationApnoeaALTEOSApH-MIIChildren
Article
This Policy Statement was retired May 2012 More than 25 years have elapsed since continuous cardiorespiratory monitoring at home was suggested to decrease the risk of sudden infant death syndrome (SIDS). In the ensuing interval, multiple studies have been unable to establish the alleged efficacy of its use. In this statement, the most recent research information concerning extreme limits for a prolonged course of apnea of prematurity is reviewed. Recommendations regarding the appropriate use of home cardiorespiratory monitoring after hospital discharge emphasize limiting use to specific clinical indications for a predetermined period, using only monitors equipped with an event recorder, and counseling parents that monitor use does not prevent sudden, unexpected death in all circumstances. The continued implementation of proven SIDS prevention measures is encouraged.
Article
Gastroesophageal reflux (GER), defined as passage of gastric contents into the esophagus, and GER disease (GERD), defined as symptoms or complications of GER, are common pediatric problems encountered by both primary and specialty medical providers. Clinical manifestations of GERD in children include vomiting, poor weight gain, dysphagia, abdominal or substernal pain, esophagitis and respiratory disorders. The GER Guideline Committee of the North American Society for Pediatric Gastroenterology and Nutrition has formulated a clinical practice guideline for the management of pediatric GER. The GER Guideline Committee, consisting of a primary care pediatrician, two clinical epidemiologists (who also practice primary care pediatrics) and five pediatric gastroenterologists, based its recommendations on an integration of a comprehensive and systematic review of the medical literature combined with expert opinion. Consensus was achieved through Nominal Group Technique, a structured quantitative method. The Committee examined the value of diagnostic tests and treatment modalities commonly used for the management of GERD, and how those interventions can be applied to clinical situations in the infant and older child. The guideline provides recommendations for management by the primary care provider, including evaluation, initial treatment, follow-up management and indications for consultation by a specialist. The guideline also provides recommendations for management by the pediatric gastroenterologist. This document represents the official recommendations of the North American Society for Pediatric Gastroenterology and Nutrition on the evaluation and treatment of gastroesophageal reflux in infants and children. The American Academy of Pediatrics has also endorsed these recommendations. The recommendations are summarized in a synopsis within the article. This review and recommendations are a general guideline and are not intended as a substitute for clinical judgment or as a protocol for the management of all patients with this problem.
Article
Seventy-five infants and children presenting during the period December 1984 to December, 1987 with the clinical features of vomiting, failure to thrive, chronic cough, recurrent pneumonia and atypical asthma were evaluated for gastroesophageal reflux by standard barium esophagram. Fifty six cases (74.7%) and as many as 80% of the infants studied had gastroesophageal reflux; Grade II reflux was seen in 12 cases, Grade III in 30 and Grade IV in 14 cases. The patients with gastroesophageal reflux were put on medical treatment. All the patients had subjective improvement after 6 weeks to 6 months of conservative treatment and none of them developed further complications of gastroesophageal reflux during a follow-up period varying from two months to fifteen months. Anti-reflux surgery was not considered owing to the subjective improvement in all the patients on conservative treatment. We conclude that gastroesophageal reflux is very common in infants and children and urge the need to evaluate the patients presenting with the symptoms suggesting gastroesophageal reflux by barium esophagram; conservative treatment is the mainstay in the management of these children.
Article
To determine whether regurgitation might be a factor in the pathogenesis of apnea in certain infants, we compared the frequency of short and prolonged apnea immediately following regurgitation to that during control periods. Ten infants (nine preterm and one term) with histories of frequent regurgitation and also apneic spells were studied for 2 to 3 hours by monitoring nasal airflow, abdominal respiratory movements, electrocardiogram, pharyngeal pH, and pharyngeal pressure. In six of these infants additional observations were made without the intrapharyngeal recording devices. Fourty-four episodes of regurgitation were observed. Both prolonged apnea (P less than 0.05) and short apnea (P less than 0.01) occurred much more frequently during regurgitation than during the control period; however, the majority of prolonged apneic spells observed were unassociated with regurgitation. The increased frequency of apnea during regurgitation was not related to the presence of intrapharyngeal recording devices. Although nasal regurgitation was frequently associated with short apnea, no prolonged apnea was observed during the seven episodes of nasal regurgitation observed. The 14-fold increase in prolonged apnea frequency immediately following regurgitation supports the hypothesis for a causal relationship between apnea and regurgitation.
Article
Fifteen infants with a specific clinical history including awake apnea were evaluated and compared with a control group of infants, using 24-hour studies of esophageal pH, nasal thermistor, impedance pneumography, and heart rate. Thirteen of the 15 children with awake apnea had clearly documented episodes of airway obstruction in associated with gastroesophageal reflux occurring at least twice during the study (mean 3.9 +/- 0.7, range 2 to 9). The control group did not show similar findings. All 15 children with awake apnea had frequent episodes of gastroesophageal reflux. Treatment with home monitoring and reflux precautions was successful in 10 of 15. Five children received therapy with urecholine hydrochloride because of continuing episodes of reflux-associated apnea. Two children subsequently required Nissen fundoplication, primarily for symptoms of severe esophagitis. Our data suggest that in children with awake apnea, the apnea is associated with gastroesophageal reflux. Medical management is usually successful, but fundoplication may be needed in refractory cases.
Article
To determine the prevalence of symptoms associated with overt gastroesophageal reflux (GER) during the first year of life, to describe when most infants outgrow these symptoms, and to assess the prevalence of parental reports of various symptoms associated with GER and the percentages of infants who have been treated for GER. Cross-sectional survey. Nineteen Pediatric Practice Research Group practices in the Chicago, Ill, area (urban, suburban, and semirural). A total of 948 parents of healthy children 13 months old and younger. None. Reported frequency of regurgitation. Regurgitation of at least 1 episode a day was reported in half of 0- to 3-month-olds. This symptom decreased to 5% at 10 to 12 months of age (P < .001). Peak reported regurgitation was 67% at 4 months; the prevalence of symptoms decreased dramatically from 61% to 21% between 6 and 7 months of age. Infants with at least 4 episodes daily of regurgitation showed a similar pattern (P < .001). Peak regurgitation reported as a "problem" was most often seen at 6 months (23%); this prevalence decreased to 14% at 7 months of age. Parental perception that regurgitation was a problem was associated with the frequency and volume of regurgitation, increased crying or fussiness, reported discomfort with spitting up, and frequent back arching. Reported treatment for regurgitation included a change in formula in 8.1%, thickened feedings in 2.2%, termination of breast-feeding in 1.1%, and medication in 0.2%. Complaints of regurgitation are common during the first year of life, peaking at 4 months of age. Many infants "outgrow" overt GER by 7 months and most by 1 year. Parents view this symptom as a problem more often than medical intervention is given.
Article
An association of apnea and gastroesophageal reflux (GER) was proposed previously. However, pH metry as the standard diagnostic tool for GER only measures acid reflux (pH < 4). It is difficult to interpret studies in infants with a presumed association between apnea and GER based on pH metry because the buffering effect of feeding may result in predominantly nonacid GER. The aim of this study was to investigate the temporal association of apnea and GER with the pH-independent intraluminal impedance technique (IMP). Infants with recurrent regurgitation or respiratory symptoms suggestive of apnea were investigated simultaneously with IMP, pH monitoring, and polygraphy. IMP patterns, pH, oronasal flow, and chest wall movement were recorded and analyzed. In 22 infants, 364 GER episodes were recorded by IMP. One hundred and sixty five apneas were documented by visual validation of polygraph records. Forty-nine apneas (29.7%) were associated with GER; 11 (22.4%) of these showed acid reflux (pH < 4). A significant correlation between the time spent apneic and GER was found (P < 0.001). There is marked association between apnea and gastroesophageal reflux in infants. Patients potentially at risk cannot be reliably identified by pH metry. Its exclusive use is therefore not suitable for the detection of all GER-associated apneas in infants. The pH-independent intraluminal impedance technique has proven to be a sensitive diagnostic tool for this approach.
Article
Monitoring oesophageal pH conventionally detects "acid reflux" (pH less than 4). The pH of the gastric contents determines whether or not reflux can be detected. To monitor gastric and oesophageal pH simultaneously in order to determine the effect of milk feeds on gastric pH and how this would influence interpretation of the oesophageal pH record. Milk fed infants for whom oesophageal pH monitoring was requested underwent simultaneous gastric and oesophageal pH monitoring using a dual channel pH probe. Twenty of 24 records were technically satisfactory. Mean reflux index was 1.0%, range 0.0-4.0%. Gastric pH was less than 4 for 24.5% (range 0.6-69.1%) of the total time. The average time the gastric pH was greater than 4 after feeds was 130 minutes (range 29-212 minutes). The corrected reflux index (limited to the time the gastric pH was less than 4) was 2.6% (range 0.0-11.0%). The pH of the gastric contents may be greater than 4 for prolonged intervals, during which oesophageal pH monitoring using current criteria cannot detect reflux nor correlate it with clinical events. A low reflux index may reflect prolonged buffering of gastric acidity rather than the absence of reflux.
Article
Aspiration is the leading cause of pneumonia in the intensive care unit and the most serious complication of enteral tube feeding (ETF). Although aspiration is common, the clinical consequences are variable because of differences in nature of the aspirated material and individual host responses. A number of defense mechanisms normally present in the upper aerodigestive system that protect against aspiration become compromised by clinical events that occur frequently in the critical care setting, subjecting the patient to increased risk. The true incidence of aspiration has been difficult to determine in the past because of vague definitions, poor assessment monitors, and varying levels of clinical recognition. Standardization of terminology is an important step in helping to define the problem, design appropriate research studies, and develop strategies to reduce risk. Traditional clinical monitors of glucose oxidase strips and blue food coloring (BFC) should no longer be used. A modified approach to use of gastric residual volumes and identification of clinical factors that predispose to aspiration allow for risk stratification and an algorhythm approach to the management of the critically ill patient on ETF. Although the patient with confirmed aspiration should be monitored for clinical consequences and receive supportive pulmonary care, ETF may be continued when accompanied by appropriate steps to reduce risk of further aspiration. Management strategies for treating aspiration pneumonia are based on degree of diagnostic certainty, time of onset, and host factors.